A Study Of Stress Management Digital App For NHL

Overview

About this study

The purpose of this study is to explore the needs of the non-Hodgkin lymphoma (NHL) community and better understand preferences for digital trials.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

adults (≥ 18 years)
NHL diagnosis (any subtype) or a caregiver of a patient with this diagnosis.
undergoing a second line or higher chemotherapy, targeted or immune therapy.
can read and understand English/study materials.
access to a smartphone or tablet, and 6) reports a distress score of ≥ 4 at eligibility screen.

Exclusion Criteria:

current hospitalization.
undergoing allogeneic or autologous transplant within the next 6 months.
current CBT participation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/9/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Janae Kirsch, Ph.D., L.P.	Contact us for the latest status

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Janae Kirsch, Ph.D., L.P.

Contact us for the latest status

More information

Publications

Publications are currently not available

Clinical Trials